Sponsored Content
Sponsored Content
Sponsored Content
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media & Events
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Sponsored Content
GSK Share
Price
GSK Share
News1
GSK Share
Chat5
GSK Share
Trades11,090
GSK
Live RNS
GSK Share
Charts
GSK Level 2
Console
GSK Live
Share Price
GSK Broker
Ratings
GSK Directors
Deals
GSK Financial
Diary
GSK
Fundamentals
GSK Short
Positions
GSK
Media
GSK Company
Research
Glaxosmithkline Information
Buy GSK Shares
Add GSK to Watchlist
Add GSK to Alert-
Last checked at -
Last checked at Share Price Information for Glaxosmithkline (GSK)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
1,459.50
Bid:
1,459.00
Ask:
1,459.50
Change:
-1.00 (-0.07%)
Spread:
0.50 (0.034%)
Open:
1,456.00
High:
1,462.00
Low:
1,439.00
Prev. Close:
1,460.50
Sponsored Content
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.
Sponsored Content
| Glaxosmithkline Share Price | |
|---|---|
| Price | 1,459.50 |
| Bid | 1,459.00 |
| Ask | 1,459.50 |
| Change | -1.00 (-0.07%) |
| Volume | 7,532,432 |
| Open | 1,456.00 |
| High | 1,462.00 |
| Low | 1,439.00 |
| Prev. Close | 1,460.50 |
| Currency | GBX |
|---|---|
| Issue Country | GB |
| Shares in Issue | 4.08b |
| Market Capitalisation | £59.53b |
| Market Size | 1,500 |
| 52 Week High | 1,820.00 |
| 52 Week High Date | 15-May-2024 |
| 52 Week Low | 1,376.00 |
| 52 Week Low Date | 02-Nov-2023 |
| # Trades | 11,090 |
|---|---|
| Vol. Sold | 4,553,939 |
| Sold Value | £66.30m |
| Vol. Bought | 2,573,327 |
| Bought Value | £37.34m |
| PE Ratio | 12.00247 |
| Earnings | 121.60 |
| Dividend | 55.50 |
| Yield | 3.803% |
Recent Share Trades for Glaxosmithkline (GSK)
| Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
|---|---|---|---|---|---|---|---|---|
| 04-Oct-24 | 16:51:42 | 1,459.50 | 298 | Sell* | 1,459.00 | 1,459.50 | 4,349 | O Ordinary |
| 04-Oct-24 | 16:47:02 | 1,457.807 | 5,874 | Sell* | 1,459.00 | 1,459.50 | 85.63k | O Ordinary |
| 04-Oct-24 | 16:35:53 | 1,459.50 | 2,580 | Sell* | 1,459.00 | 1,459.50 | 37.66k | A Automatic Execution |
| 04-Oct-24 | 16:35:21 | 1,459.50 | 4,260 | Sell* | 1,459.00 | 1,459.50 | 62.17k | O Ordinary Trade was executed as an SI |
| 04-Oct-24 | 16:35:21 | 1,459.50 | 9,675 | Sell* | 1,459.00 | 1,459.50 | 141.21k | O Ordinary Trade was executed as an SI |
| 04-Oct-24 | 16:35:21 | 1,459.50 | 2,375 | Unknown* | 1,459.00 | 1,459.50 | 34.66k | O Ordinary Was reported as OTC |
| 04-Oct-24 | 16:35:21 | 1,459.50 | 2,387,045 | Sell* | 1,459.00 | 1,459.50 | 35m | UT Uncrossing Trade |
| 04-Oct-24 | 16:04:24 | 1,461.00 | 0 | Unknown* | 1,605.00 | 1,313.00 | 0.00 | O Ordinary Delayed publication Was reported as OTC |
| 04-Oct-24 | 16:15:30 | 1,459.00 | 1 | Unknown* | 1,605.00 | 1,313.00 | 14.59 | O Ordinary Delayed publication Was reported as OTC |
| 04-Oct-24 | 16:15:08 | 1,459.50 | 0 | Unknown* | 1,532.00 | 1,313.00 | 0.00 | O Ordinary Delayed publication Was reported as OTC |
Directors Deals for Glaxosmithkline (GSK)
| Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
|---|---|---|---|---|---|---|---|
| 24-Sep-24 | 23-Sep-24 | Buy | Vishal Sikka held the position of Independent Non-Executive Director at the time of this trade.Vishal Sikka | 20.51 | USD | 1,546 | 253,469,335 |
| 24-Sep-24 | 23-Sep-24 | Buy | Jesse Goodman held the position of Independent Non-Executive Director at the time of this trade.Jesse Goodman | 20.51 | USD | 448 | 11,854 |
| 24-Sep-24 | 23-Sep-24 | Buy | Anne Beal held the position of Independent Non-Executive Director at the time of this trade.Anne Beal | 20.51 | USD | 448 | 4,072 |
| 24-Sep-24 | 23-Sep-24 | Buy | Hal Barron held the position of Non-Executive Director at the time of this trade.Hal Barron | 20.51 | USD | 448 | 3,380,013 |
| 24-Sep-24 | 23-Sep-24 | Buy | Jeannie Lee held the position of Non-Executive Director at the time of this trade.Jeannie Lee | 20.51 | USD | 448 | 741 |
Share Discussion for Glaxosmithkline (GSK)
Glaxosmithkline
At GSK, we unite science, technology and talent to get ahead of disease together
Sponsored Content
